| Followers | 167 |
| Posts | 42797 |
| Boards Moderated | 3 |
| Alias Born | 10/20/2019 |
Thursday, July 08, 2021 12:02:07 PM
$RMTI has two FDA-approved therapies indicated for patients undergoing hemodialysis, which are the first two products developed from the FPC platform. Rockwell Medical is also advancing its FPC platform by developing FPC for the treatment of iron deficiency anemia in patients outside of dialysis, who are receiving intravenous medications in the home infusion setting.
In addition, Rockwell Medical is one of two major suppliers of life-saving hemodialysis concentrate products to kidney dialysis clinics in the United States.
In addition, Rockwell Medical is one of two major suppliers of life-saving hemodialysis concentrate products to kidney dialysis clinics in the United States.
Recent RMTI News
- Rockwell Medical Renews Product Purchase Agreement with aQua Dialysis • Business Wire • 05/20/2026 10:00:00 AM
- Rockwell Medical Signs New 3-Year Product Purchase Agreement with Heritage Dialysis • Business Wire • 05/14/2026 10:00:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/11/2026 08:16:03 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2026 09:00:52 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 11:14:09 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2026 10:59:14 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2026 10:16:19 AM
- Rockwell Medical Announces First Quarter 2026 Results and Additional 2026 Guidance with Focus on Profitability • Business Wire • 05/07/2026 10:00:00 AM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/30/2026 01:00:09 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/30/2026 10:59:07 AM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 04/20/2026 08:09:05 PM
- Rockwell Medical to Release First Quarter 2026 Results on Thursday, May 7, 2026 • Business Wire • 04/09/2026 10:00:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 11:30:28 AM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/26/2026 11:01:16 AM
- Rockwell Medical tops earnings forecasts but shares slip on revenue decline • IH Market News • 03/26/2026 10:50:34 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/26/2026 10:10:47 AM
- Rockwell Medical Announces Fourth Quarter and Full-Year 2025 Financial and Operational Results • Business Wire • 03/26/2026 10:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/16/2026 10:11:46 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/16/2026 10:10:57 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/16/2026 10:10:11 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/16/2026 10:09:30 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/16/2026 10:08:43 PM
